clinical trial diversity

CISCRP Fall 2023 Campaign

CISCRP: Supporting Patient Diversity Campaign Fall 2023

Clincierge is proud to support CISCRP in a new educational initiative to increase awareness about clinical research and the level of understanding among minority communities across the U.S.We have united to circulate an informative full-page advertorial spread highlighting the key importance of diversity in clinical studies to discover treatments that are effective for everyone.

CISCRP: Supporting Patient Diversity Campaign Fall 2023 Read More »

Sickle Cell Awareness Month

National Sickle Cell Awareness Month: Increasing Understanding and Health Equity

In the United States (US), the month of September is National Sickle Cell Awareness Month. In 1976, the National Association for Sickle Cell Disease (NASCD) launched a series of public awareness campaigns and started reaching out to local, state, and federal legislators. In 1983, then-President Ronald Reagan signed Proclamation 5102 into law, proclaiming each September

National Sickle Cell Awareness Month: Increasing Understanding and Health Equity Read More »

CISCRP Diversity Ad Spring 2023

CISCRP: Supporting Patient Diversity Campaign Spring 2023

Clincierge is proud to support CISCRP in a new educational initiative to increase awareness about clinical research and the level of understanding among minority communities across the U.S.We have united to circulate an informative full-page advertorial spread highlighting the key importance of diversity in clinical studies to discover treatments that are effective for everyone.

CISCRP: Supporting Patient Diversity Campaign Spring 2023 Read More »

Health Equity and DEI: Are They Synonymous?

The Five-Percent Rule: Strategies to Increase Clinical Trial Participation Rates

A recent article by Applied Clinical Trials references a widely-held statistic that as few as 5% of eligible patients have participated in a clinical trial related to their disease. While some within the pharmaceutical industry debate the validity of this figure, all agree the low level of participation is concerning for all clinical research stakeholders.

The Five-Percent Rule: Strategies to Increase Clinical Trial Participation Rates Read More »

ESG Ratings FAQs: The Process, Rating Levels, and Reason Why They Matter

ESG Rating FAQs: The Process, Rating Levels, and Reasons Why They Matter

EcoVadis, the leading global supply chain environmental, ethical, and social performance ratings platform, recently awarded Clincierge a Bronze rating. This score places Clincierge in the top 50% of all companies evaluated by EcoVadis. Clincierge Earns Bronze Sustainability Rating from EcoVadis Clincierge was recognized for the following in this inaugural business review: Commitment to employee diversity

ESG Rating FAQs: The Process, Rating Levels, and Reasons Why They Matter Read More »

error: Protected content.